Skip to main content
Apeloa Pharmaceutical Co.,Ltd. logo

Apeloa Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 000739 ISIN · CNE000000Q45 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,843 across all filing types
Latest filing 2013-04-23 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000739

About Apeloa Pharmaceutical Co.,Ltd.

https://www.apeloa.com

Apeloa Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company operates three core business pillars: API production, Contract Development and Manufacturing Organization (CDMO) services, and finished drug products. Its therapeutic focus includes cardiovascular, anti-infective, anti-viral, and oncology treatments. Apeloa utilizes an integrated supply chain to deliver chemical and biological solutions to a global client base. The organization maintains compliance with international quality standards, including certifications from the FDA, EMA, and PMDA. Its CDMO services encompass the full product lifecycle, from process chemistry and analytical development to large-scale commercial manufacturing, supported by specialized technology platforms such as continuous flow chemistry and enzymatic synthesis.

Recent filings

Filing Released Lang Actions
关于对安徽普洛康裕制药有限公司增加注册资本的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding an increase in registered capital of a subsidiary company, detailing the capital injection amount, parties involved, and the purpose of the capital increase. It references the board resolution and the need for shareholder approval. There are no financial statements or comprehensive financial performance data presented. The document is relatively short (975 characters) and serves as a formal announcement of a capital increase event rather than a full financial report or detailed financing update. Given the content focuses on capital structure change and the increase of registered capital, the most appropriate classification is 'Capital/Financing Update (CAP)'.
2013-04-23 Chinese
第五届监事会第十一次会议决议
Regulatory Filings Classification · 95% confidence The document is a resolution from the Supervisory Board meeting of 普洛股份有限公司 (Puluo Co., Ltd.) held on April 22, 2013. It discusses the approval of the 2012 Annual Report, Supervisory Board Work Report, General Manager Work Report, Financial Work Report, profit distribution and capital reserve conversion plan, appointment of the Board Secretary, daily related party transactions forecast for 2013, and internal control self-evaluation report. The document is a formal meeting resolution with voting results and references to other announcements for detailed reports. It does not contain the full annual report or detailed financial statements itself but rather the decisions made in the meeting regarding these reports and proposals. The document length is short (1614 characters) and it mainly announces the resolutions passed by the Supervisory Board. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a formal announcement of meeting resolutions and approvals, not the full Annual Report (10-K) or other detailed reports themselves.
2013-04-23 Chinese
第五届董事会第十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 16th meeting of the 5th Board of Directors of 普洛股份有限公司. It includes approvals of the 2012 annual report, board work report, general manager's report, financial work report, profit distribution plan, appointment of board secretary, internal control self-evaluation report, capital increase, mergers, guarantees, and amendments to company bylaws. The document also mentions that many of these resolutions require shareholder approval at the general meeting. The content is focused on board meeting decisions and management appointments rather than the full annual report itself. The document length is 3266 characters, which is relatively short and more consistent with a board meeting resolution announcement rather than a full annual report. Therefore, the document fits best under the category of Board/Management Information (MANG), as it announces board meeting resolutions and management changes.
2013-04-23 Chinese
2012年年度报告
Annual Report Classification · 100% confidence The document is titled as the 2012 Annual Report of 普洛股份有限公司 (Apeloa Company Limited). It contains detailed sections typical of an annual report, including company overview, financial data and indicators, board of directors report, important matters, shareholder information, governance, internal control, and a comprehensive financial report section. The document length is about 15,000 characters, indicating a full report rather than a brief announcement. It includes audited financial data, management discussion, and detailed financial statements. The presence of an audit opinion and detailed financial and operational data confirms this is the full Annual Report for the fiscal year 2012. Therefore, the correct classification is Annual Report (10-K). FY 2012
2013-04-23 Chinese
关于两家控股子公司吸收合并的公告
M&A Activity Classification · 95% confidence The document is an announcement regarding the absorption merger of two subsidiaries of the company 普洛股份有限公司. It details the merger process, the companies involved, the financials of the subsidiaries, and the procedural steps for the merger. There is no indication that this is a full annual or interim report, audit report, or earnings release. It is not a regulatory filing or certification. The document is a corporate announcement about a merger activity within the company, specifically an absorption merger of subsidiaries. This fits best under the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids. The document length is short and focused on the merger announcement, not a full merger filing (MA) or tender offer. Therefore, the classification is M&A Activity (TAR) with high confidence.
2013-04-23 Chinese
2013年日常关联交易预计公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the company's expected daily related-party transactions for the year 2013. It includes descriptions of the nature of these transactions, involved parties, transaction amounts, pricing principles, approvals by the board and independent directors, and the necessity of these transactions for normal business operations. The document references compliance with Shenzhen Stock Exchange listing rules and the China Securities Regulatory Commission guidelines. It is not a full financial report but rather a regulatory announcement about related-party transactions, including board approvals and independent director opinions. The document length is over 7,000 characters and contains substantive content about the transactions, but it is primarily an announcement of expected related-party transactions and their governance rather than a financial report or earnings release. This fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories.
2013-04-23 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.